We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
HSKA

Price
-
Stock movement up
+- (%)
Company name
Heska Corporation
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
1.31B
Ent value
1.34B
Price/Sales
6.32
Price/Book
992.83
Div yield
0.33%
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
799.93
PEG
-
EPS growth
-
1 year return
31.18%
3 year return
13.53%
5 year return
2.42%
10 year return
32.94%
Last updated: 2024-12-17

DIVIDENDS

HSKA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA1084.96
EV to EBITDA1111.03

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales6.32
Price to Book992.83
EV to Sales6.47

FINANCIALS

Per share

Loading...
Per share data
Current share count10.91M
EPS (TTM)-3.04
FCF per share (TTM)-3.57

Income statement

Loading...
Income statement data
Revenue (TTM)207.37M
Gross profit (TTM)88.01M
Operating income (TTM)-12.68M
Net income (TTM)-15.01M
EPS (TTM)-3.04
EPS (1y forward)0.15

Margins

Loading...
Margins data
Gross margin (TTM)42.44%
Operating margin (TTM)-6.12%
Profit margin (TTM)-7.24%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash4.69M
Net receivables9.85M
Total current assets26.98M
Goodwill0.00
Intangible assets2.16M
Property, plant and equipment0.00
Total assets37.47M
Accounts payable7.38M
Short/Current long term debt12.26M
Total current liabilities25.15M
Total liabilities36.15M
Shareholder's equity1.32M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-14.04M
Capital expenditures (TTM)3.57M
Free cash flow (TTM)-17.61M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-1138.13%
Return on Assets-40.06%
Return on Invested Capital-110.73%
Cash Return on Invested Capital-129.88%

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
HSKAS&P500
Current price drop from All-time high-56.24%-8.59%
Highest price drop-98.97%-56.47%
Date of highest drop9 Mar 20099 Mar 2009
Avg drop from high-75.28%-11.07%
Avg time to new high148 days12 days
Max time to new high5716 days1805 days
COMPANY DETAILS
HSKA (Heska Corporation) company logo
Marketcap
1.31B
Marketcap category
Small-cap
Description
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.
Employees
808
Investor relations
-
SEC filings
CEO
Kevin S. Wilson
Country
USA
City
Loveland
Stock type
Common stock
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner